Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2020 3903
2021 5259
2022 4060
2023 1049
2024 1736
2025 951

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14,800 results

Results by year

Filters applied: . Clear all
Page 1
Drug repurposing for the treatment of COVID-19.
Kato Y, Nishiyama K, Nishimura A, Noda T, Okabe K, Kusakabe T, Kanda Y, Nishida M. Kato Y, et al. J Pharmacol Sci. 2022 Jul;149(3):108-114. doi: 10.1016/j.jphs.2022.04.007. Epub 2022 Apr 25. J Pharmacol Sci. 2022. PMID: 35641023 Free PMC article. Review.
Drug treatment for Covid-19 - three years later.
Trémolières F. Trémolières F. Infect Dis Now. 2023 Oct;53(7):104761. doi: 10.1016/j.idnow.2023.104761. Epub 2023 Jul 14. Infect Dis Now. 2023. PMID: 37454763 Review.
Outpatient Treatment for COVID-19.
Raglow Z, Malani PN, Petty LA. Raglow Z, et al. JAMA. 2023 Oct 3;330(13):1295. doi: 10.1001/jama.2023.16666. JAMA. 2023. PMID: 37585210
Fluvoxamine for the treatment of COVID-19.
Dodds MG, Doyle EB, Reiersen AM, Brown F, Rayner CR. Dodds MG, et al. Lancet Glob Health. 2022 Mar;10(3):e332. doi: 10.1016/S2214-109X(22)00006-7. Lancet Glob Health. 2022. PMID: 35180412 Free PMC article. No abstract available.
Fluvoxamine for the treatment of COVID-19.
Marzolini C, Marra F, Boyle A, Khoo S, Back DJ. Marzolini C, et al. Lancet Glob Health. 2022 Mar;10(3):e331. doi: 10.1016/S2214-109X(21)00592-1. Lancet Glob Health. 2022. PMID: 35180411 Free PMC article. No abstract available.
Fluvoxamine for the treatment of COVID-19.
Kim H, Manzi S, Gonzelez-Heydrich J, Picker J. Kim H, et al. Lancet Glob Health. 2022 Mar;10(3):e330. doi: 10.1016/S2214-109X(22)00003-1. Lancet Glob Health. 2022. PMID: 35180410 Free PMC article. No abstract available.
ACE2, a drug target for COVID-19 treatment?
Liu Y, Huang H. Liu Y, et al. Ir J Med Sci. 2023 Apr;192(2):919-921. doi: 10.1007/s11845-022-03055-1. Epub 2022 Jun 14. Ir J Med Sci. 2023. PMID: 35699908 Free PMC article. No abstract available.
Small molecules in the treatment of COVID-19.
Lei S, Chen X, Wu J, Duan X, Men K. Lei S, et al. Signal Transduct Target Ther. 2022 Dec 5;7(1):387. doi: 10.1038/s41392-022-01249-8. Signal Transduct Target Ther. 2022. PMID: 36464706 Free PMC article. Review.
[Treatment of COVID-19].
Yatera K. Yatera K. Nihon Yakurigaku Zasshi. 2022;157(4):214-220. doi: 10.1254/fpj.22019. Nihon Yakurigaku Zasshi. 2022. PMID: 35781447 Japanese.
14,800 results
You have reached the last available page of results. Please see the User Guide for more information.